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The surface phenotype ofmurine NK cells, freshlyobtained from untreated mice
or from mice in which spontaneous cytotoxicity has been boosted with IFN or IFN
inducers such as poly(I:C) or acute virus infections, is well characterized (1-3) . Al-
though both freshly obtained splenic NK cells and in vitro cultured NK cells (1)
do not express most markers present on the majority of B (sIg) or T cells (CD3 ;
CD8, Lyt2 ; CD4, L3T4), they sharewith T and myelomonocytic cells othermarkers
(asialo GM1, Thy-1, Qa-2, Qa-5, and CR3) . NK cells from appropriate strains ex-
pressaunique allospecific marker, NK-1 .1 (4, 5), that is restricted toNK cells (reviewed
in reference 6) . The murine NK cell phenotype resembles that ofhuman NK cells .
In humans the most useful marker to distinguish both freshly isolated and cultured
NK cells from other lymphocytes is a low affinity receptor for the Fc portion of im-
mune complexed IgG (CD16 or human [hu] t FcyRIII) (7) . This FcyR is shared
with granulocytes and macrophages (8, 9), is antigenically and biochemically dis-
tinct from otherknown FcyR (10), and allows NK cells to mediate antibody-dependent
cell-mediated cytotoxicity (ADCC) (11) .
Indirect evidence that murine NK cells bear FcyR is provided by data showing
that : (a) removal of FcyR-bearing cells from a spleen cell population, by absorption
on monolayers ofIgG-sensitized erythrocytes (EA7S), significantly reduces, although
nevercompletely abolishes, its spontaneouscytotoxicity against tumor cells (12) ; and
(b) a relevant proportion of the splenic lymphocytes that form conjugates with the
NK-sensitive target YAC-1 belong to thelymphocyte subset that forms rosettes with
EAIgG2b (13) . However, no direct evidence exists forthe presence ofadefined FcyR
on murine NK cells . Indeed, in one study, FcyR was not detected on cultured NK
cell clones (14) .
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Murine macrophages express three distinct FcyR types (15, 16). All cell types ex-
pressing any ofthe three receptors form EA7S rosettes, and rosette formation using
indicator systems sensitized with polyclonal IgG cannot distinguish among them
(reviewed in reference 10). mAb 2AG2 detects an FcyR expressed at high density
on mouse macrophages and, at lower density, on B and T lymphocytes (mouse [mo]
Fc7RII) (17), which binds murine IgG2b, IgGl, and IgG2a with low affinity (17-19).
Functional properties of the FcyR are inhibited by antibody 2AG2 both in vitro
and in vivo (20-22). The genes encoding moFcyRII recognized by 2AG2 have been
cloned (23-25) and isolated. cDNA probes are derived from transcripts oftwo different
genes, a and /3; a appears to be expressed solely in macrophages (23). Two (3 gene
transcripts, 01 and (32, have been identified. (31, and possibly (32, is expressed in
2.4G2' B and T cell lines, whereas only 02 is expressed in macrophage-like cell lines
(23).
In this paper we report direct evidence that both fresh and cultured murine NK
cells express on their surface a functional FcyR recognized by antibody 2AG2. In
contrast to macrophages or B and T lymphocytes, murine NK cells express only
FcyRa transcripts.
Materials and Methods
Cell Lines.
￿
The murine mastocytoma P815, thymoma YAC-1, B cell lymphoma BCL,,
T cell lymphomas EL-4, S49.1, and CTLL, the macrophage-like cells P388D, and J774a,
and the fibroblast L cells were maintained in culture in RPMI 1640 (Flow Laboratories, Rock-
ville, MD) medium supplemented with 1070 FCS (Gibco Laboratories, Grand Island, NY).
All cell lines were mycoplasma-free on repeated testing.
Antibodies.
￿
mAbs 2AG2 (anti-moFc RII) (17), PK136 (anti-NK-1.1) (5), and 3C7 (anti-
IL-2R) were kindly provided by Drs. J. Unkeless (Mount Sinai Hospital, New York, NY),
G. Koo (Merck, Sharp and Dohme Research Laboratories, Rahway, NJ), and T Malek (Miami
University, Miami, FL), respectively. Antibody F4/80 (26), recognizing a specific macro-
phage marker, was obtained from Dr. P. Witte (University of Texas, Dallas, TX). Antibody
anti-Macl (anti-CDllb) was prepared from cells obtained from the American Type Culture
Collection (American Type Culture Collection, Rockville, MD). B137.17 is a murine IgG2a
with no known antigen specificity. Polyclonal sera anti-asialo GM1 and anti-NK-2.1 were
purchased from Wako Chemicals (Dallas, TX) and kindly provided by Dr. R. Burton (Univer-
sity of Newcastle, Australia), respectively. The FITC-labeled mAbs antiThy-1, anti-Lyt-1,
anti-Lyt-2, anti-L3T4 and anti-I-A were kindly provided by Dr. J. Cebra (University ofPenn-
sylvania, Philadelphia, PA) . When indicated, the antibodies were labeled with biotin or FITC
according to standard procedures. The rabbit IgG anti-bovine E used to prepare EA7S and
the polyclonal affinity-purified FITC-labeled goat F(ab')2 anti-murine IgM and IgG anti-
bodies were obtained from Cooper Laboratories (Malvern, PA). The goat anti-murine Ig
used for indirect rosetting and the mouse C3H anti-DBA/2 polyclonal antibodies used for
ADCC were produced in our laboratories (1, 7).
Lymphocyte Preparations.
￿
BALB/c, C3H/He, C57BL/6, and DBA/2 mice were obtained from
The Jackson Laboratories (Bar Harbor, ME); the (C57BL/6 x DBA/2)F, [(B6D2)Fl] hy-
brid mice were produced as previously described (27) . C.B-17 scid/scid (severe combined im-
munodeficiency, scid) mice were produced under specific pathogen free conditions at the Univer-
sity of Texas (Dallas, TX). When indicated, mice were injected with poly(I:C) (Pharmacia
Inc., Piscataway, NJ), 50 ug i.p., 24 h before they were killed. Spleens were teased and splenic
lymphocytes were obtained by Ficoll/Hypaque (F/H) density gradient centrifugation (1.092
± 0.001 g/ml). When indicated, the total lymphocyte preparations were depleted of macro-
phages and B lymphocytes by adherence to plastic and/or direct rosetting with CrC13-treated
goat anti-mouse Ig-coated sheep E and density-gradient centrifugation as previously described
(7). 2AG2' and 2.4G2 - subsets were obtained from sIg lymphocytes by sorting on an OrthoPERUSSIA ET AL.
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Cytofluorograf 50H, connected to a 2100 Data Analyzer (Ortho Instruments, Westwood, MA),
after sensitization with biotin-labeled 2AG2 and FITC-avidin (Vector Laboratories, Burlin-
game, CA) as previously described (28). In vitro propagated NK cells were prepared as de-
scribed (29, 30). Briefly, NK-1.1' cells were selected from nylon-wool passaged and Percoll-
fractionated (B6D2)Fl mouse splenocytes using indirect immunofluorescence and FACS
(FACStar; Becton Dickinson & Co., Mountain View, CA). NK-1.1' cells (95% pure, on
FACS reanalysis) or unfractionated scid splenocytes were cultured (105, 106 cells/ml, respec-
tively) at 37'C for 5-11 d in RPMI 1640 (Gibco Laboratories) supplemented with 10 ° 70 FCS
and 500 U/ml human rIL-2, generously provided by Cetus Corp. (Emeryville, CA).
immunofluorescence andFACS
￿
The surface phenotype of the cells was detected with mAbs
using direct and indirect immunofluorescence (flow cytometry) using biotin-labeled antibodies
and FITC-avidin or FITC-labeled antibodies, as indicated, according to previously published
procedures (31). Fluorescence intensity was measured on either exponential or linear scales,
as indicated. Two-color immunofluorescence was performed as previously described (31) using
predetermined saturating concentrations of FITC-labeled antibodies and of biotin-labeled
antibodies detected with phycoerythrin (PE)-labeled avidin (Becton Dickinson & Co.).
Cell-mediated Cytotoxicity.
￿
Spontaneous and antibody-dependent cytotoxicity were tested
at several E/T cell ratios using 5'Cr-labeled YAC-1 and antibody-sensitized P815 cells as target
cells(104/well) in either 18-h or 4-h assays, as indicated. To quantitate cytotoxicity, lytic units
(LU) were calculated on the basis oflinear regression analysis to a modified Von Grogh equa-
tion according to established methods (7) and referred to the absolute number of cells recov-
ered. 1 LU is defined as the number of effector cells that kills 45 ,70 of the targets (LU [45 % ])
during the test period. When indicated, anti-moFcyRII and rat control isotype-matched an-
tibodies (ascites, 1 :200 dilution) were present in the E/T cell mixture.
FcyR Functional Assay.
￿
The ability of cell surface FcyR to bind immune complexes was
tested using EA7S as indicator system in rosetting assays, as previously described (8).
FcyR mRNA Detection.
￿
To define the gene(s) encoding the FcyRII in murine NK cells,
Northern blot analysis was performed on mRNA obtained from either (B6D2)Fl NK1 .1 `
or C .B-17 scid NK2.1' spleen cells that were propagated in 500 U/ml rIL-2 for 11 and 5 d,
respectively. Methods for RNA preparation, fractionation in agarose gels, transfer to nylon
membranes, hybridization with 12P-labeled probes, and stripping of filters for rehybridiza-
tion were as described previously (29). RNAs were also prepared from the BCL,, EL4, and
P388D, cell lines. The FcyRa+ /3 probe is a 1.0-kb Nco I restriction fragment excised from
the FcyRa cDNA clone (23). This probe detects FcyRa/(31/(32 mRNA. Specific probes were
obtained from the 5' portion of the FcyRa and FcyR02 cDNA clones. The a-specific probe
is a 125-bp Hinf I-Alu I fragment and the /3-specific probe is a 115-bp Hinf I fragment. Each
fragment contains 5'-untranslated sequences as well as the coding region for the signal pep-
tide. cDNA probes for MHC class II I-E,fl (32) and /3-actin (33) were used as controls. In-
tegrity and quantity ofmRNA loaded per lane (20 ug) were monitored by ethidium bromide
staining of the gels and by hybridization with the /3-actin probe.
RNaseProtection.
￿
A cDNA probe encoding the mouse FcyRa gene (23) was inserted into
the pGEM-3 vector and used to generate uniformly-labeled antisense RNA. A 920-bp run-off
transcript was generated by linearizing the cloned cDNA at the Bgl II site. Labeling and
protection were performed essentially as described by the manufacturer (Promega-Biotec,
Madison, WI). Briefly, 10 t~g of total RNA from P388D,, J774a, S49.1, L cells and the in
vitro propagated NK cell populations described above were hybridized (55 0C, 16 h) to the
probe in a reaction mixture that included 80% formamide, 0.4 M NaCl, and 0.04 M Pipes,
pH 6.4. The unprotected RNA was digested with RNase A (34°C, 90 min) and the protected
fragments were analyzed on a 5% acrylamide, 8M urea, Tris-Borate-EDTA (TBE) gel. The
gel was dried and allowed to expose x-ray film for 6 h.
Results
A SmallProportion of sIg SplenicLymphocytes Bear FcyRII.
￿
Since treatment of mice
with poly(I:C) induces a slightly increased number of NK cells without altering the7 6
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phenotype or function of other lymphocyte populations (2), mice were pretreated
with poly (I:C) in most experiments. About 50 ° Io of murine splenic lymphocytes
from all strains tested reacted with anti-Fc-yRII antibody 2AG2. To analyze whether
all 2 .4G2+ cells were sIg + B lymphocytes, additive staining experiments were per-
formed. The proportion of cells detected using each mixture of two antibodies was
compared with the sum of those obtained using each antibody separately. The per-
centage of BALB/c splenic lymphocytes detected with a combination of 2AG2 and
either anti-Lyt-2 or anti-L3T4 antibodies did not differ significantly from the sum
of those detected with each antibody separately (Table I), indicating that the anti-
bodies detect discrete lymphocyte populations . Combination of 2AG2 with either
anti-Ig or anti-I-A antibody detected an additional 7 % of positive lymphocytes com-
pared with the number of cells detected with either anti-Ig or anti-I-A alone, whereas
combination of 2AG2 and antiThy-1 antibodies detected a proportion ofcells -7 %
lower than the sum of those positive with 2AG2 and antiThy-1 separately. These
data indicate that ti7% of the splenic lymphocytes coexpress the 2AG2 and Thy-1
antigens, but not sIg, I-A, Lyt-2, or L3T4.
Similar experiments were performed on lymphocytes from C57BL/6 spleens
depleted of sIg+ cells by direct rosetting with CFC13-treated goat anti-mouse
Ig-coated E. The proportion of sIg+, 2 .4G2 + and NK-1 .1 + cells in the original
spleens were, on average, 43 .4, 47.4, and 11.3%, respectively. The proportion of sIg+
4
TABLE I
Reactivity of Murine Splenic Lymphocytes with
Anti-FcyRII Antibody 2.4G2
BALB/c mice were injected with poly(I:C) 24 h before they were killed. Splenic
lymphocytes were purified by density gradient centrifugation. Direct immune-
fluorescence was performed using FITC-labeled avidin to detect the different
biotin-labeled antibodies, alone or in combination with 2AG2.
Percent positive cells, mean ± SD (three experiments).
The sIg population was purified from the total splenic lymphocytes of
C57BL/6 mice by rosetting with CrCl_;-treated goat anti-mouse Ig-coated E.
Direct immunofiuorescence was performed, as for BALB/c mice . Experiment
representative of three performed.
FcyR were detected by resetting lymphocytes with EA7S, as described in
Materials and Methods, in the absence or presence of a 10-2 dilution of the
ascites of the indicated antibodies.
Strain Antibody
Added
None
antibody
2AG2
BALB/c None 0.5 ± 0.1 * 47.8 ± 3 .8
(total cells) Anti-Ig 50.3 ± 8.6 57.9 + 5 .2
Anti-I-A 45,0 + 11 .4 60.9 ± 5 .7
Anti-Thy-1 51 .5 ± 6.6 91 .7 ± 2 .0
Anti-Lyt-2 15 .1 ± 5.7 64 .3 ± 9.4
Anti-L3T4 31 .4 ± 2.6 77 .2 + 2.4
C57BL./6$ None 0.8 13 .4
(s1g- cells) Anti-Ig 4.1 17 .2
NK-1 .1 8.4 12.1
Anti-Ig + NK-1 .1 11 .9 13.5
EA7S9 12.1 0.1
EA7 + NK-1 .1 12.4 0.1PERUSSIA ET AL .
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lymphocytes in the sIg- population was reduced by >90% (Table I) . Although the
proportion of 2AG2' lymphocytes was also decreased, on average 10% of the sIg-
lymphocytes expressed FcyRII, as indicated by their reactivity with antibody 2AG2
and binding of EA7S.
The proportion of NK-1.1' cells was similar in the total splenocyte population
and in the sIg- lymphocytes . The percentage of cells positive with a combination
of NK1 .1 and anti-Ig was equal to the sum of those positive with each antibody
separately, suggesting that the two reagents recognize two discrete subsets of lym-
phocytes, NK and B cells, respectively. The proportion of cells positive with a com-
bination of NK-1 .1 and 2AG2 antibodies was almost identical to that of the cells
positive with 2AG2 antibody alone, an indication that these antibodies reacted with
the same subset of cells . As is the case in total spleen cell preparations (data not
shown), antibody 2AG2, but not NK-1.1, completely inhibited EA7S rosette forma-
tion by sIg- lymphocytes .
2.4G2Reacts with Freshly ObtainedSplenicNK Cells .
￿
To test directly whether moFcyRII
is expressed onNK cells, two-color immunofluorescence experiments were performed,
using 2AG2 and NK-1 .1 antibodies, with C57BL/6 splenic lymphocytes . In these
lymphocyte preparations the average proportion of sIg+ and of 2AG2' cells were
53 .5 and 58 .2%, respectively. The vast majority (average 97 .7%) of sIg' lympho-
cytes (Fig . 1) coexpressed 2AG2, but 8.3% of the lymphocytes were positive with
2AG2 and not with anti-Ig . This proportion is similar to that of the NK-1.1' cells
(9.1% on average) . Most NK-1 .1' cells (92.5%) coexpressed the 2AG2 antigen,
whereas only a minor proportion of the 2AG2' cells (15.4%) expressed NK-1 .1
antigen .
FcyRII-bearing Lymphocytes Mediate Spontaneous Cytotoxicity.
￿
Splenocytes from all
strains of mice are spontaneously cytotoxic to YAC-1 target cells . To determine the
phenotype of the YAC-1-responsive cells, FcyRII' and FcyRII - lymphocytes were
FtcURE 1 .
￿
NK-1.1' splenicNK cells express FcyRII . Total splenic lymphocytes were obtained
from poly(I:C) treated C57BL/6 mice (experiment representative offive performed) . Two-color
immunofluorescence was performed using FITC-labeled anti-Ig or2AG2 (green fluorescence)
and 2AG2 or NK-1 .1 mAbs labeled with biotin anddetected with PE-avidin (red fluorescence) .
Correlate measurements of green (x-axis, log scale) and red (y-axis, log scale) fluorescence are
displayed as two-dimensional contour plots . Based on the negative control samples in the pres-
ence of PE- and FITC-avidin only, the contour plots were divided into quadrants indicating:
(1) cells with red fluorescence (binding PE-avidin only) ; (2) double-positive cells; (3) double-negative
cells ; (4) cells with green fluorescence (binding FITC-labeled antibody only) . The numbers on
the scales refer to arbitrary units of fluorescence intensity.78
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separated by FRCS from sIg- spleen cell preparations and the cytotoxic activity of
each population was tested (Fig. 2). Cytotoxicity mediated by the sIg' cells from
BALB/c and C3H/HeN mice was 10- and 20-fold lower, respectively, than that medi-
ated by the sIg- cells (43 and 20 LU [45%] compared with 527 and 411 LU [45%]).
The slg-/2 .4G2' cells mediated levels ofcytotoxicity similar to (BALB/c) or slightly
higher (C3H/HeN) than those mediated by the total sIg- cells. On a per cell basis,
spontaneous cytotoxicity mediated by slg-/2.4G2 - cells was -50-70% lower than
that mediated by either total or 2.4G2'/sIg- cells.
In Vitro Propagated NK Cells Express Functional FcyRII.
￿
NK cells, obtained from
(B6D2)F1 mice and propagated in vitro with rIL-2, were tested for expression of
the 2AG2 antigen. The majority of these cells maintained a cell-surface phenotype
similar to that of fresh NK cells (34), i.e., Lyt-2 and L3T4-, sIg- (34), F4/80-,
IL-2R(3C7) -, but low-density Thy-1' (29 and data not shown), asialo GM1' and
NK-1 .1' (Fig. 3). The TCR molecules (a, a, and ,y chains) and CD3 are not ex-
pressed in these cells (29, 30, and data not shown) . The observation that in vitro
propagated NK cell populations are F4/80- rules out the possibility that they are
contaminated with macrophages expressing the 2AG2 antigen. FcyRII, as detected
using antibody 2AG2, was expressed on the majority ofthese cells (Fig. 3) at a den-
sity higher than that on fresh NK cells, but reproducibly lower than that on murine
macrophages or B cells (not shown). NK cells propagated in vitro were unable to
bind monomeric murine IgG2a, as detected by binding of FITC- or biotin-labeled
murine IgG2a B137.17 (Fig. 3). These NK cells propagated in vitro are potent effectors
of spontaneous cytotoxicity (27, and data not shown) and ADCC (Fig. 4). Antibody
2AG2, but not other isotype-matched control antibodies, present during the ADCC
B C3H/HeN
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FIGURE 2.
￿
2.4G2'/slg- lymphocytes mediate spontaneous cytotoxicity. Splenic lymphocytes were
purified by density gradient centrifugation from poly(I:C)-treated BALB/c (A)or C3H/HeN (B)
mice (experiments representative of three performedwith each mouse strain). sIg* (")and sIg-
cells(") were separated from the lymphocyte preparations by rosetting with CrC13-treated goat
anti-mouse Ig coated E and density gradient centrifugation. 2AG2' (A) and 2.4G2 - (") cells
were obtained from the sIg- populations by indirect rosetting after sensitization with 2AG2.
Spontaneous cytotoxicity of each population was tested against 'ICr-labeled YAC-1 target cells
(104/well) in an 18-h assay.W m
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FIGURE 3.
￿
Antibody 2AG2 reacts with in vitro propagated murine NK cells. NK-1.1' cells,
purified by FRCS from spleens of (B6D2)F1 mice and propagated in culture in the presence of
HL-2 (500 U/ml) were tested for expression of the indicated cell surface markers by indirect im-
munofluorescence after staining with the indicated antibody (solid line). Background fluorescence
with the second antibody alone (dotted line). x-axis, intensity of fluorescence (log scale, top and
middle panels; linear scale, bottom panels); y-axis, number of cells.
assay, resulted in inhibition of the antibody-dependent killing to levels ofcytotox-
icity similar to those observed on non-Ab-sensitized target cells.
TheFcyRIIExpressedonNKCellsIs Encodedby theFcyRa Gene.
￿
To determine which
ofthe FcTR genes encode the Fc7R11 polypeptide(s) expressed on the surfaceofNK
cells, Fc7R cDNA fragments were used to probe mRNA isolated from NK1.1' cells
from (B6D2)FI and from NK-2.1' cells from scid mice propagated in vitro. The
mRNA transcripts in cultured (B6D2)FI splenic NK cells detected by the Fc-yRa+0
probe, i.e., the complete FcyRa cDNA that hybridizes to transcripts ofboth a and
(3 genes (23), appear as one single band migrating faster than those in cell lines EL4
and BCLI (Fig. 5 A). No hybridization was observed with the control CTLL cell
line. EL4 and BCLI express only the FcyR01 gene, and both FcyRa and FcyRR280
￿
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FIGURE 4 . Anti-FcyRII antibody
2AG2 inhibits NK cell-mediated
ADCC . Cytotoxicity ofin vitro propa-
gated NK-1 .1 ` cells was tested against
P815 targets, sensitized or not with
C3H anti-DBA/2 immune serum, in
a 4-h "Cr release assay . (N) Nonsen-
sitized targets ; (" ) antibody-sensitized
targets (ADCC) ; (" ) ADCC in the
presence of2AG2 (ascites, 10-2 dilu-
tion) ; (A) ADCC in the presence of
isotype-matched control antibody
Mac-1 .
RNA have higher mobility than Fc7R01 RNA (23) . FcyRa- and /3-specific cDNA
fragments hybridize with RNA from the macrophage line P388Dt, producing two
bands of sizes compatible with those ofFcyRa and Fc7R02 transcripts, respectively
(reference 23 and Fig . 5 A) . To distinguish between expression ofFcyRa and Fc7RO
RNA inNK cells, the specific probes were hybridized toRNA from cultured C.B-17
scid splenic NK cells (Fig . 5 B) . NK cellRNA hybridized only to the common FcyR
FIGURE 5 .
￿
Specificity of FcyR transcripts in NK cells. RNA was isolated from splenic NK-1.1'
and NK-2.1' NK cells, originally purified from normal (B6D2)Fl (A) or C.B-17 scid mice (B),
and cultured (11 and 5 d, respectively) in the presence of500 U/ml rIL-2 . FcyR RNA expression
in these culturedNK cells was analyzed relative to reference cell lines EL4, BCLI, and P388D1 .
Migration of the 18S and 28S ribosomal RNA markers is indicated.PERUSSIA ET AL .
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probe and to the FcyRa-specific probe . As expected, BCLi RNA hybridized only
to the common FcyR probe and to the FcyRO-specific probe . To rule out the possi-
bility that the propagated NK cells contained macrophages expressing FcyRa tran-
scripts, the same filter was hybridized with acDNA probe specific forMHC class
II I-E/3 ; no detectable class IIRNA waspresent in theNK cell preparation (Fig . 5 B) .
RNase protection assay indicates that the FcyRa transcript in NK cells is iden-
tical to that in the macrophage-like linesJ774a (not shown) and P388Dt (Fig . 6) .
An antisense probe that corresponds to the a transcript, extending from the Bgl
11 site within the region encoding the EC2 domain (23) to the polyadenylation site,
was protected as a full-length 920-bp fragment by RNA derived from P388Dt and
J774a cells (lane 3, and not shown) and from in vitro propagated NK cells (lane
4), indicating that this region of the FcyRa transcript is identical in NK cells and
macrophages . FcyRa and /3 transcripts share >95% homology in their extracellular
domains. Crosshybridization of the 920-bp a-antisense probe to 01 and 02 tran-
FIGURE 6 .
￿
RNase protection of FcyRa tran-
scripts in NK cells. RNA from a-expressing
P388D I andNK cells protecta full-length, 920-
bp fragment (lanes 3and 4) ; RNA from /32- or
/31-expressing cells crosshybridize with the probe
and results in protection of 160- and95-bp frag-
ments (lanes 3and5, respectively) . No bands were
observed when RNA from the FcyR negative L
cells was used (lane 6) ; control sense RNA pro-
tects the full-length probe (lane 7).82
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scripts should generate fragments of 160 and 95 bp, respectively. The (32-expressing
P388Di cell line (lane 3) and the /31-expressing T cell line 549.1 (lane 5) demon-
strate the expected bands. The Fc7Ra is not expressed in T cells, accounting for
the absence of the 920-bp band, whilea was not expressed in the J774a variant (19,
and not shown).
Discussion
We present evidence that murine NK cells, like human NK cells, bear a func-
tional FcyR that triggers ADCC . The moFcyRIIa gene is the only FcyRII gene
expressed in murine NK cells and presumably encodes this FcyR.
mAb 2AG2 recognizes murine FcyRII, a highly glycosylated protein migrating
in SDS-PAGE as a broad band of 50-70 kD (17), expressed on macrophages and
B cells. The affinity (2 .4G2)-purified FcyRII binds murine IgGl/IgG2a/IgG2b (17,
18) and has biochemical characteristics very similar to those of the FcyR(CD16) ex-
pressed on human NK cells, neutrophilic granulocytes and macrophages (8, 9). Thus,
this antibody was used to test the hypothesis that murine NK cells bear an FcyR
equivalent to the human FcyR (CD16). A small population of Thy-1+ cells that bear
2AG2 but neither sIg or I-A determinants are found in splenic lymphocytes from
a variety of mouse strains. Murine NK cells express Thy-1 antigen at low density
but neither CD4 (L3T4) nor CD8 (Lyt-2) (27, 29). Our data, indicatingno overlap
between the 2 .4G2 +/Thy-1 + and the CD4 or CD8+ populations, are consistent with
the hypothesis that the 2.4G2+/Thy-1+ cells are not T cells. The existence of this
2.4G2 +/slg- lymphocyte subset was confirmed using B cell-depleted spleen lym-
phocytes. The observation that CrC13-treated anti-mouse Ig-coated E do not bind
to lymphocyte populations depleted of sIg+ cells by nylon wool adherence (not
shown) makes it unlikely that a significant proportion of NK cells are lost, using
this procedure, in the B cell rosetting population. The 2.4G2 +/slg- subset purified
in this way is unlikely to represent sIg- B cells or macrophages, because it lacks
expression of MHC class II determinants and it is present in spleen cell prepara-
tions depleted of macrophages by adherence to plastic. The identification of the
sIg -/2.4G2+ cells as NK cells is supported by the fact that, in C57BL/6 spleen, the
2.4G2 +/slg- cell subset coexpresses the NK-specific antigen NK-1.1. Nonspecific
binding of antibody NK-1.1 to the FcyR of 2AG2 + cells through its Fe portion is
excluded because antibody NK-1.1 does not inhibit EA7S rosette formation by ei-
ther total or slg- cells and does not bind to spleen lymphocyte preparations from
BALB/c mice that do not express NK-1 .1 alloantigen but express FcyR and 2AG2
determinant (data not shown) . Although we did not use F(ab')2 fragments of anti-
body 2AG2, it is unlikely that the antibody binds to FcR on the positive cellsthrough
its Fc portion because all experiments have been performed in the presence of excess
human IgG, previously shown to block nonspecific Fc binding.
The 2.4G2 +/sIg- cells mediate higher levels of spontaneous cytotoxicity, on a per
cell basis, than the sIg-/2 .4G2 - cells. However, the absolute number of LU recov-
ered in the two populations is not significantly different. Several possibilities may
explain these results. Similar functional consequences occur in human NK cells upon
FcyR(CD16) interaction with anti-FcyR(CD16) antibodies and immune complexes
(35). Low spontaneous cytotoxicity in murine 2AG2+ cells may reflect down-
modulation of this activity induced by the interaction of FcyR with anti-FcyR anti-PERUSSIA ET AL.
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bodies, similar to that previously reported with both human (36) and mouse cells
(12). Also, 2.4G2 - NK cells might exist, in analogy with the small proportion of
human NK cells that reportedly do not express Fc7R(CD16) (37). However, our
inability to recover all spontaneous cytotoxicity in 2AG2+ cells is most likely due
to thelowdensitywithwhichthisepitopeisexpressed and the insufficient sensitivity
ofavailable separation techniques to completely deplete the cells expressing the an-
tigen at the lowest density.
The low density expression ofthe FcyR detected by 2AG2 on murine NK cells
was confirmed using highly homogeneous NK-1.1+ cells purified from (B6D2)Fl
spleen cells. Like the FcyR on fresh NK cells, the FcyRII detected by 2AG2 on cul-
tured NK cellsare functional, and endowNK cells with ADCC activity. The ability
ofantibody 2AG2 at high concentrations to completely inhibit ADCC supports the
hypothesis that FcyRII is the major, if not the only, FcyR type expressed on NK
cells. Lack of binding of monomeric IgG2a to NK cells excludes the presence of
the high affinity FcTRI. However, we cannot exclude the possibility that other, as
yet unidentified FcyR type(s) are also present on NK cells.
Our data provide the first direct evidence that a single FcyRII RNA transcript
is expressed in murine NK cells and that the FcyRIIa transcripts present in NK
cells are identicalto thosepresent in macrophages. Thesedata suggest that the FcyR
expressed in murine NK cells is encoded by the FcyRIIa gene.
Antibody 2AG2 reacts with the extracellular domain of any ofthe proteins en-
coded by FcyRII genes (19) and our data show that the epitope detected by 2AG2
is responsible forFcyR-dependent functionsalso on thesecells, as previously reported
in macrophages (19). Although FcyRII molecules encoded by the different genes
appear to bind IgG with the same specificity, a correlation exists, within the 2.4G2+
cell types tested, between expression of the FcyRIIa gene and ability to mediate
ADCC. Recent data (Kuziel, W., and P W. Tucker, manuscript in preparation) in-
dicate that FcyRIIa transcripts are also uniquely expressed in a TCR-y/S+ subset
ofmurine dendritic epidermal cells (38) able to mediate ADCC. Although the ex-
tracellular domains of the FcyR are similar, the transmembrane and cytoplasmic
domains of the FcyRa-encoded protein bear no homology with the respective do-
mains of the Fc-yRol or R2-encoded proteins (23). The apparent requirement for
an FcyRa-encoded receptor for ADCC activity suggests that features of these two
domains may be responsible for this FcyR-mediated function, possibly via a role
in signal transduction. The observation that only FcyRa transcripts are detectable
in NK cells, as opposed to (31 transcripts in lymphocyte tumor lines and both the
a and (32 transcripts in macrophages, may also bear on the lineage to which these
cells belong.
A gene encoding huFcyR(CD16), the only type ofFcyR expressedon human NK
cells, has been cloned recentlyfrom ahumanplacenta cDNAlibrary (39) and reported
to have the greatest sequence homology with the moFc7Ru cDNA. The homology
between the two genes extends throughout the transmembrane portion ofthe mole-
cule, bearing no or minimal homology, in this portion ofthe molecule, to the other
FcyR types defined at present. In human neutrophils, FcyR(CD16) lacks an in-
tracytoplasmic domain and is anchored to the membrane through glycosyl-
phosphatidyl inositol (GPI) (39, 40). In contrast to theGPI-linked form in granulo-
cytes, a transmembrane form of FcyR(CD16) exists: macrophages from patients84
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affected with paroxysmal nocturnal hemoglobinuria, who have an impaired ability
to form GPI anchors (41), express FcyR(CD16). Furthermore, FcyR(CD16) on both
fresh and cultured human NK cells and FcyRII on murine NK cells are insensitive
to doses of PI-specific phospholipase C (PI-PLC), which cleaves 90% of the
FcyR(CD16) on both fresh and cultured granulocytes, the CD14 on monocytes, and
the Thy-1 on murine T cells (reference 42 and data not shown). Two nearly iden-
tical, linked genes for huFc7R111(CD16) have been cloned and sequenced (42). These
genes (111-1 and III-2) are transcribed in a cell type-specific fashion to generate the
two alternatively anchored forms of the receptor on neutrophils and NK cells. The
FcyRIII(CD16) sequence for the NK cells molecule encodes a transmembrane pro-
tein and demonstrates homology with the moFcyR1Ia molecule, not only in its trans-
membrane domain but in its cytoplasmic domain as well. Therefore, the moFc-YR11
encoded by the Fc-yR1Ia gene in murine NK cells is the equivalent of the FcyR(CD16)
on human NK cells.
Summary
We report evidence that murine NK cells express a functional FcyRII encoded
by the FcyRIla gene. Several lines of indirect evidence indicate that freshly obtained
NK cells from mice of several strains bear a functional FcyRII: (a) anti-FcyRII anti-
body 2AG2 detects a small but significant proportion of sIg- cells and a small
proportion of the 2.4G2' cells are included in the Thy-1' population; (b) sIg- lym-
phocytes contain 2.4G2' and FcyR-bearing cells in similar proportions ; (c) binding
of particulate immune complexes by sIg- lymphocytes is completely inhibited by
2.4G2 ; (d) 2 .4G2' cells mediate >50% of the spontaneous cytotoxicity in s1g-
splenic lymphocytes. Direct evidence for the presence of FcyRII on murine NK cells
is provided by the results of two-color immunofluorescence studies performed on
splenic lymphocytes from C57BL/6 mice showing coexpression of NK-1.1 and 2AG2.
Studies of in vitro propagated homogeneous NK cell populations confirm that mu-
rine NK cells express only FcyRII and that this FcyR is functional, as shown in
experiments of inhibition ofADCC by the anti-FcyRII antibody 2AG2 . The results
of studies at the molecular level show that an FcyR11ce transcript identical to that
expressed in macrophages is the only molecule encoding FcyRII in murine NK cells.
We are indebted to Dr. J. Unkeless and G. Koo for their generous gifts of antibodies 2AG2
and NK-1.1, respectively. We thankJ. Faust for assistance at the cytofluorograph, M. Hoffman
for editing, and M. Kaplan for secretarial assistance. We are grateful to Dr. B. Knowles for
critical discussions.
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